| 000 | 01290 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514003025.0 | ||
| 264 | 0 | _c20010726 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0270-9139 | ||
| 024 | 7 |
_a10.1053/jhep.2001.25883 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArguedas, M R | |
| 245 | 0 | 0 |
_aImmunogenicity of hepatitis A vaccination in decompensated cirrhotic patients. _h[electronic resource] |
| 260 |
_bHepatology (Baltimore, Md.) _cJul 2001 |
||
| 300 |
_a28-31 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aBilirubin _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHepatitis A Antibodies |
| 650 | 0 | 4 |
_aHepatitis A Vaccines _xadverse effects |
| 650 | 0 | 4 |
_aHepatitis Antibodies _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Cirrhosis _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aProthrombin Time |
| 700 | 1 | _aJohnson, A | |
| 700 | 1 | _aEloubeidi, M A | |
| 700 | 1 | _aFallon, M B | |
| 773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 34 _gno. 1 _gp. 28-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/jhep.2001.25883 _zAvailable from publisher's website |
| 999 |
_c11360965 _d11360965 |
||